OVERVIEW

Webinar Replay: Part 2: iRECIST (Response Evaluation Criteria in Solid Tumours) Workshop is organized by Association of Clinical Research Professionals (ACRP).

Webinar Replay Expires April 1, 2023

Description:
In oncology clinical trials, the assessment of changes in tumor burden is a primary endpoint. For solid tumors, RECIST 1.1 is the established criteria. However, as we move from chemotherapeutic trials into immunotherapeutic trials, a new response to treatment patterns has become evident. A subset of patients to have increased tumor burden that is followed by a clear response or prolonged stabilization of cancer. iRECIST guidelines have been developed to capture this new response pattern. Part 1 of 2 presentations introduced you to the history of the iRECIST guidelines, the iRECIST process, and how iRECIST is being used in oncology clinical trials. This Webinar, Part 2, will consist of a workshop using hypothetical cases to determine iRECIST responses.

Upon completion of this webinar, attendees will be able to:
• Understand the history and need for the development of the iRECIST guidelines
• Define terms of tumor measurement and objective change in tumor burden in iRECIST
• Review hypothetical cases to determine iRECIST response

Pricing Without Contact Hours
Member: $0
Nonmember: N/A

Additional details will be posted as soon as information is available.